GLAXOSMITHKLINE PLC | 19,45 Euro | -0,225 -1,14 % | |
| WKN: 940561 ISIN: GB0009252882 Ticker-Symbol: GS7 | Xetra | 19.06.13 | 17:36 Uhr |
Branche PharmaAktienmarkt FTSE-100STOXX Europe 50 |
|
| |||||||||||||||||||||
| |||||||||||||||||||||||
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 19.06. | Glaxo Gets Offer for Thrombosis Drugs | - | Zacks | |
| 19.06. | Aspen extends gains on R10bn GSK deal | 3 | Moneyweb | |
| 19.06. | Aspen proposes to acquire GSK's thrombosis brands and NDB site | 3 | Pharma Bus Review | |
| 18.06. | GSK, Aspen in $1bn drugs deal | 1 | IOL | |
| 18.06. | GlaxoSmithKline Gets Offer For Its Thrombosis Brands From Aspen Pharmacare | 31 | AFX News | |
| LONDON (dpa-AFX) - U.K.-based drug maker GlaxoSmithKline plc (GSK, GSK.L)
said Tuesday that it has received an offer for its thrombosis brands and a
related production site in France from... Mehr lesen zu: GlaxoSmithKline Gets Offer For Its Thrombosis Brands From Aspen Pharmacare | ||||
| 18.06. | Glaxo Gets Offer for Heart Drugs With Declining Sales | 2 | Bloomberg | |
| 18.06. | Aspen jumps on latest GSK deal | 2 | IOL | |
| 18.06. | UPDATE 1-GSK negotiating $1 bln sale of thrombosis drugs to Aspen | 2 | Reuters.com | |
| 18.06. | GSK negotiating $1 billion sale of thrombosis drugs to Aspen | - | Reuters.com | |
| 18.06. | Aspen to buy thrombosis drugs from GSK | 1 | IOL | |
| 18.06. | GSK receives offer for thrombosis brands | 1 | ShareCast | |
| 18.06. | GlaxoSmithKline Gets Offer From Aspen For Thrombosis Brands | 15 | AFX News | |
| LONDON (dpa-AFX) - U.K.-based drug maker GlaxoSmithKline plc (GSK, GSK.L)
Tuesday said it received an offer for its thrombosis brands and Notre-Dame de
Bondeville or NDB site from Aspen... Mehr lesen zu: GlaxoSmithKline Gets Offer From Aspen For Thrombosis Brands | ||||
| 18.06. | GlaxoSmithKline PLC GSK receives offer for Thrombosis Brands | - | Euroinvestor | |
| 18.06. | GlaxoSmithKline (GSK) Receives Bid for Thrombosis Brands, NDB Site | - | StreetInsider.com | |
| 18.06. | S.Africa's Aspen offers to buy GSK thrombosis drugs | 1 | Reuters.com | |
| 18.06. | GSK receives offer for thrombosis brands | - | StockMarketWire | |
| 18.06. | GlaxoSmithKline PLC: GSK receives offer for Thrombosis Brands | - | InvestEgate | |
| 17.06. | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 17.06.2013: BEIERSDORF, DEUTSCHE BOERSE, DEUTSCHE POST, DEUTSCHE TELEKOM, ENI, E.ON, GAGFAH, GEA GROUP, GERRY WEBER, GLAXOSMITHKLINE, HANNOVER RUECK, HEIDELBERGER ... | 718 | dpa-AFX | |
| Ausgewählte Analysten-Einstufungen im
dpa-AFX-Nachrichtendienst vom 17.06.2013
BEIERSDORF
LONDON - Die US-Bank JPMorgan hat die Einstufung für Beiersdorf
auf "Underweight" belassen. Die jüngsten... Mehr lesen zu: dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 17.06.2013: BEIERSDORF, DEUTSCHE BOERSE, DEUTSCHE POST, DEUTSCHE TELEKOM, ENI, E.ON, GAGFAH, GEA GROUP, GERRY WEBER, GLAXOSMITHKLINE, HANNOVER RUECK, HEIDELBERGER ... | ||||
| 17.06. | GLAXOSMITHKLINE PLC - 6-K, Report of foreign issuer | - | SEC Filings | |
| 17.06. | Gallileo: IVG übernimmt Commerzbank-Gebäude mit GSK und Linklaters | 238 | JUVE | |
Seite: 1 2 3 4 5 ... Weiter >>
882 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von